PureRawz Expands Batch-Tested Peptide Research Catalog to Meet Growing Demand from Independent and Academic Investigators
PureRawz announced a significant expansion of its batch-tested peptide research supply catalog, introducing an extended range of high-purity investigational compounds, including BPC-157, TB-500, Ipamorelin, and CJC-1295, supported by third-party Certificate of Analysis (CoA) documentation for each product lot.
The expansion addresses a documented gap in the research supply market: the availability of consistently verified, batch-specific peptide compounds for independent investigators and academic laboratories. PureRawz’s updated catalog provides researchers with access to compounds accompanied by independent laboratory testing data, lot-specific purity percentages, and standardized compound specifications. Each listed compound is identified by its IUPAC name, molecular weight, and CAS registry number, allowing researchers to cross-reference supply records against published preclinical literature without ambiguity.
The catalog expansion responds to supply-side disruptions that have affected the peptide research community in early 2026. The closure of several established research compound suppliers left a substantial portion of the investigator community without reliable sourcing for compounds central to ongoing preclinical studies. A survey conducted by the Independent Peptide Research Network indicated that more than 60 percent of responding researchers reported difficulty sourcing batch-verified peptides following vendor consolidations in the sector. PureRawz’s expanded offering is positioned to serve that unmet demand by maintaining continuous stock availability and consistent lot documentation across its peptide catalog.
PureRawz described the catalog expansion as an extension of its existing quality infrastructure rather than a new standalone initiative. Batch testing has been a standard component of the company’s fulfillment process, and the current expansion scales that infrastructure across a broader compound range. Researchers accessing the PureRawz research peptide catalog can review CoA documents before procurement, compare lot-specific purity data, and submit compound specification inquiries directly through the product listing interface. Order records, lot numbers, and associated CoA files are stored within each user’s account history to support laboratory recordkeeping and reproducibility documentation.
Independent research coordinators who have sourced from PureRawz cited consistent documentation as a primary factor in supplier selection. One research procurement coordinator noted that lot traceability and accessible CoA data reduced the administrative burden associated with compound sourcing for multi-stage preclinical protocols. PureRawz reported that catalog request volume for batch-documented peptides increased by over 40 percent in the first quarter of 2026, a figure the company attributed to broader market displacement and growing institutional emphasis on compound provenance documentation.
PureRawz positioned the expanded catalog as suitable for a range of investigative contexts, including university-affiliated laboratories, contract research organizations, and independent investigators conducting preclinical studies. The compounds available through the catalog are not approved by the U.S. Food and Drug Administration (FDA) and are intended strictly for research purposes only, not for human or veterinary use. All catalog listings carry explicit research-use designations, and procurement is limited to verified research accounts in jurisdictions where investigational compound sourcing is permitted.
PureRawz emphasized that the expanded peptide supply line operates within the same platform used for compound specification lookup, bulk order management, and research account documentation, aligning supply-side demand with the broader research workflow infrastructure already in place for existing catalog users. The company stated that this integration is intended to reduce friction in the research procurement process for investigators who rely on PureRawz as their primary compound supply source.
About PureRawz
PureRawz is a research compound supply company that provides batch-tested investigational peptides, selective androgen receptor modulators (SARMs), and research chemicals to independent investigators, academic laboratories, and contract research organizations. The company maintains a catalog of compounds supported by third-party Certificate of Analysis documentation and operates in accordance with research-use supply standards across North America. All compounds supplied by PureRawz are intended strictly for laboratory research purposes and are not approved for human or veterinary use.
Media Contact
Contact Person: Purerawz Team
Company: Purerawz
Email: support@purerawz.co
Website: https://purerawz.co/
Address: New York USA